Basic Information
Basic information for LINC00343-323-20aa-2
Peptide Name LINC00343-323-20aa-2
Genome Position chr13:105761394-105761437,105763740-105763755[+]
Species Human
Peptide Sequence MHSLSILWKDSHHNEIWEDT
Peptide Length 20
Unique No (LINC00343-202-20aa-1,LINC00343-225-20aa-3,LINC00343-243-20aa-1,LINC00343-252-20aa-2,LINC00343-258-20aa-2,LINC00343-264-20aa-2,LINC00343-294-20aa-1,LINC00343-299-20aa-1,LINC00343-303-20aa-1,LINC00343-321-20aa-3,LINC00343-324-20aa-2)
Grand Average of Hydropathicity -0.87
Relative Molecular Mass 2821.01
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000670771;LINC00343-323
Transcript Length 1983
Coding Ability 0.4937
DNA Sequence Corresponding to Peptide ATGCATAGCCTGTCGATACTTTGGAAGGATTCTCATCATAACGAGATATGGGAGGACACC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :